HOPWA's death in the House sets stage for negotiations with Senate. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HOPWA's death in the House sets stage for negotiations with Senate. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Policy Law. 1995 Apr 7;10(6):1-2. Unique Identifier : AIDSLINE AIDS/95700283

Abstract: The U.S. House of Representatives has called for the elimination of the Housing Opportunities for People with AIDS (HOPWA) program while the Senate has yet to decide HOPWA's fate. Activists are hoping the Senate conferees will persuade their House counterparts to spare HOPWA and that HOPWA's fate will be brought up during the House Appropriations Committee conference. Arguments are being made by sympathetic congressmen and women that there is a need by about 60 percent of people with AIDS for housing assistance. The alternative is longer hospitalization stays at an enormous burden to the taxpayers. Bipartisan support is emerging. On March 24th, the Senate Appropriations Committee left intact fiscal 1995 spending for HOPWA, the Ryan White Comprehensive AIDS Resources Emergency Act, and a host of prevention and research programs.
Keywords: *Acquired Immunodeficiency Syndrome Financing, Government Housing/ECONOMICS/*LEGISLATION & JURISPRUD Human *Politics NEWSLETTER ARTICLEKWDacquiredimmunodeficiencysyndromefinancing,governmenthousing/economics/KWDlegislation&jurisprudhumanKWDpoliticsnewsletterarticle
951030
M95A0940

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .